StockData
Kamada Ltd logo

Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30
$8.16+0.05 (+0.62%)

Close on Nov 17, 2026Market cap $470.72MP/E –Yield –

Kamada operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Kamada's operating cash flow for the twelve months ending Jun 30, 2026 was $35.76M, down 10.9% year over year. For fiscal 2025 it was $25.49M, down 46.4% from the year before. The highest annual figure on record is $47.59M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.49M-46.4%
FY2024Dec 31, 2024$47.59M+1003.0%
FY2023Dec 31, 2023$4.32M-84.9%
FY2022Dec 31, 2022$28.59M–
FY2021Dec 31, 2021-$8.82M-146.2%
FY2020Dec 31, 2020$19.11M-30.7%
FY2019Dec 31, 2019$27.57M+161.4%
FY2018Dec 31, 2018$10.55M+192.3%
FY2017Dec 31, 2017$3.61M+90.2%
FY2016Dec 31, 2016$1.90M–
FY2015Dec 31, 2015-$13.98M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.07M+125.3%
Q1 FY2026Mar 31, 2026-$291.00K–
Q4 FY2025Dec 31, 2025$7.57M-27.2%
Q3 FY2025Sep 30, 2025$10.42M-53.1%
Q2 FY2025Jun 30, 2025$8.02M-42.6%
Q1 FY2025Mar 31, 2025-$513.00K-150.3%
Q4 FY2024Dec 31, 2024$10.40M+135.8%
Q3 FY2024Sep 30, 2024$22.21M+2311.8%
Q2 FY2024Jun 30, 2024$13.96M+668.0%
Q1 FY2024Mar 31, 2024$1.02M–
Q4 FY2023Dec 31, 2023$4.41M-84.6%
Q3 FY2023Sep 30, 2023$921.00K+16669.8%
Q2 FY2023Jun 30, 2023$1.82M-83.3%
Q1 FY2023Mar 31, 2023-$2.85K-100.1%
Q4 FY2022Dec 31, 2022$28.56M–
Q3 FY2022Sep 30, 2022$5.49K–
Q2 FY2022Jun 30, 2022$10.89M–
Q1 FY2022Mar 31, 2022$5.47M-57.1%
Q4 FY2021Dec 31, 2021-$4.97M-308.6%
Q3 FY2021Sep 30, 2021-$2.67M–
Q2 FY2021Jun 30, 2021-$3.28M–
Q4 FY2020Dec 31, 2020$12.75M–
Q3 FY2020Sep 30, 2020$2.38M–

More Kamada figures

See a number that looks wrong?